Delivery Order SPE2DB24D2013-SPE2DB25FCHRG
Award Date
3/19/25
Potential Completion Date
3/20/25
Potential Value
$25K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $45,298.36, is for the delivery of Dupixent 300 mg/2 ml syringes. The contract is a firm fixed-price delivery order with a performance period ending on March 4, 2025. This award is not associated with a set-aside program, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $5,004.57 for the supply of Dupixent 300 mg/2 ml syringes. The contract has an ultimate completion date of July 11, 2024 and is a Firm Fixed Price agreement. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,542.43, is a delivery order for the supply of Dupixent 300 mg/2 ml syringe, a specialty medication. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,709.46, is for the delivery of Dupixent 300 mg/2 ml syringes to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of January 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,548.79, is a delivery order for the supply of Dupixent 300 mg/2 ml syringes. The contract has a firm fixed price pricing type and an ultimate completion date of March 4, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $11,263.92, is for the delivery of Dupixent 300 mg/2 ml syringes. The contract is a Firm Fixed Price Delivery Order with a completion date of December 5, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,602.59 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml syringes, with an ultimate completion date of October 16, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,879.84, is a Firm Fixed Price Delivery Order for the supply of Dupixent 300 mg/2 ml syringes. The contract has an ultimate completion date of May 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,801.97 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 mL syringes. The contract has a period of performance through June 5, 2024 and was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,890.16, is for the delivery of Dupixent 200 mg/1.14 ml syringes. This appears to be a Firm Fixed Price Delivery Order, with a completion date of March 11, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...